Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.6422
-0.0392-5.75%
Post-market: 0.66490.0227+3.53%19:59 EDT
Volume:9.37M
Turnover:6.14M
Market Cap:178.53M
PE:-1.29
High:0.7000
Open:0.6741
Low:0.6345
Close:0.6814
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.56
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:5.71
PE(LYR):-2.49

Loading ...

Humacyte Says FDA Accepts IND for First-in-human CTEV CABG Study

Reuters
·
Jul 27

Humacyte Announces FDA Acceptance of Ind for First-in-Human Clinical Study of Ctev for Coronary Artery Bypass Grafting

THOMSON REUTERS
·
Jul 27

Humacyte - to Initiate Phase 2a Ctev Study in Cabg This Quarter

THOMSON REUTERS
·
Jul 27

Humacyte Names Nephrologists Kossmann, Roy-chaudhury as Dialysis Access Advisors

Reuters
·
Jul 14

BTIG Remains a Buy on Humacyte (HUMA)

TIPRANKS
·
Jun 24

Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)

TIPRANKS
·
Jun 18

Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN)

TIPRANKS
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Humacyte Inc : TD Cowen Cuts Target Price to $1.25 From $1.5

THOMSON REUTERS
·
Jun 17

Humacyte Price Target Maintained With a $2.00/Share by BTIG

Dow Jones
·
Jun 16

Humacyte says Phase 3 study shows bioengineered ATEV blood vessel beats AV fistula in women on dialysis

Reuters
·
Jun 15

Humacyte - Enters Underwriting Agreement for Underwritten Offering on June 10, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 12

Humacyte Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 11

Humacyte, Inc. : H.c. Wainwright Raises Target Price to $4 From $3

THOMSON REUTERS
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte

Reuters
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Humacyte prices 47,619,048-share follow-on offering at $1.05 each to raise $50 million

Reuters
·
Jun 11

Humacyte - Prices Public Offering of 47.62 Mln Shares at $1.05 per Share

THOMSON REUTERS
·
Jun 11

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

GlobeNewswire
·
Jun 11

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

Dow Jones
·
Jun 11